SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001047469-20-001338
Filing Date
2020-03-10
Accepted
2020-03-10 07:34:38
Documents
68
Period of Report
2019-12-31

Document Format Files

Seq Description Document Type Size
1 10-K a2240917z10-k.htm 10-K 1284098
2 EX-4.4 a2240917zex-4_4.htm EX-4.4 18132
3 EX-23.1 a2240917zex-23_1.htm EX-23.1 3697
4 EX-31.1 a2240917zex-31_1.htm EX-31.1 7778
5 EX-31.2 a2240917zex-31_2.htm EX-31.2 7786
6 EX-32.1 a2240917zex-32_1.htm EX-32.1 4451
7 EX-32.2 a2240917zex-32_2.htm EX-32.2 4463
  Complete submission text file 0001047469-20-001338.txt   6293534

Data Files

Seq Description Document Type Size
8 EX-101.INS catb-20191231.xml EX-101.INS 1536116
9 EX-101.SCH catb-20191231.xsd EX-101.SCH 40794
10 EX-101.CAL catb-20191231_cal.xml EX-101.CAL 52499
11 EX-101.LAB catb-20191231_lab.xml EX-101.LAB 427649
12 EX-101.PRE catb-20191231_pre.xml EX-101.PRE 301197
13 EX-101.DEF catb-20191231_def.xml EX-101.DEF 139081
Mailing Address ONE KENDALL SQUARE BLDG. 1400E, SUITE B14202 CAMBRIDGE MA 02139
Business Address ONE KENDALL SQUARE BLDG. 1400E, SUITE B14202 CAMBRIDGE MA 02139 617-349-1971
CATABASIS PHARMACEUTICALS INC (Filer) CIK: 0001454789 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-37467 | Film No.: 20699923
SIC: 2834 Pharmaceutical Preparations